Download PDF
CC BY-NC-ND 4.0 · AJP Rep 2018; 08(04): e212-e218
DOI: 10.1055/s-0038-1673632
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Safe Motherhood Initiative: Early Impact of Severe Hypertension in Pregnancy Bundle Implementation

Lynn L. Simpson
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York
,
Burton Rochelson
2   Division of Maternal-Fetal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York
,
Cande V. Ananth
3   Department of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University, New York, New York
,
Peter S. Bernstein
4   Division of Maternal-Fetal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
,
Mary D'Alton
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York
,
Cynthia Chazotte
4   Division of Maternal-Fetal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
,
Jessica A. Lavery
3   Department of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University, New York, New York
,
Kristin Zielinski
5   American College of Obstetricians and Gynecologists District II, Albany, New York
,
for the Safe Motherhood Initiative Severe Hypertension in Pregnancy Work Group › Author Affiliations
Further Information

Publication History

17 April 2018

21 August 2018

Publication Date:
11 October 2018 (online)

   Permissions and Reprints

Abstract

Objective To describe the implementation and early results of the American College of Obstetricians and Gynecologists District II Safe Motherhood Initiative's Severe Hypertension in Pregnancy bundle on the timely treatment of severe hypertension in New York State obstetric hospitals.

Methods This is a retrospective comparative study of two time periods during voluntary implementation of the Severe Hypertension in Pregnancy bundle in New York State's obstetric hospitals. The main outcome measure was the administration of an appropriate antihypertensive agent within 1 hour of the second elevated value for all pregnant or postpartum patients with severe hypertension.

Results Of the 117 obstetric hospitals participating in the Safe Motherhood Initiative, 111 (94.9%) submitted data included in this analysis. During the study period, 80 of the 111 (72.0%) hospitals reported implementing the hypertension bundle. Overall, 2.4% of pregnant women were diagnosed with severe hypertension, and 60 to 65% of patients were treated within an hour of the second elevated value. Although not statistically significant, a greater numbers of patients were treated within an hour of the second elevated value in the second time period compared with the first in most obstetric hospitals (overall 64.8 vs. 60.8%; p = 0.33).

Conclusion There were increasing numbers of patients receiving timely treatment of severe hypertension during early implementation of a Severe Hypertension in Pregnancy bundle in New York State obstetric hospitals. However, bundle implementation requires significant financial and human resources and the long-term impact on maternal morbidity and mortality in our state remains uncertain.

Precis There was a tendency toward more timely treatment of severe hypertension following implementation of a Severe Hypertension in Pregnancy bundle in New York obstetric hospitals.

Keywords

severe hypertension - bundle implementation - safe motherhood - timely treatment

* Author names for this group are provided in Appendix A.


Note

This work is supported by Merck for Mothers, American College of Obstetricians & Gynecologists District II's Safe Motherhood Initiative, and participating New York State obstetric hospitals.


 

  • References

  • 1 Berg CJ, Harper MA, Atkinson SM. , et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol 2005; 106 (06) 1228-1234
    CrossrefPubMedGoogle Scholar
  • 2 Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol 2015; 125 (04) 938-947
    CrossrefPubMedGoogle Scholar
  • 3 Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105 (02) 246-254
    CrossrefPubMedGoogle Scholar
  • 4 Chazotte C, D'Alton ME. Maternal mortality in New York--Looking back, looking forward. Semin Perinatol 2016; 40 (02) 132-135
    CrossrefPubMedGoogle Scholar
  • 5 Moroz LA, Simpson LL, Rochelson B. Management of severe hypertension in pregnancy. Semin Perinatol 2016; 40 (02) 112-118
    CrossrefPubMedGoogle Scholar
  • 6 GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053): 1775-1812
    CrossrefPubMedGoogle Scholar
  • 7 New York State Maternal Mortality Review Team, Division of Family Health. New York State Maternal Mortality Review Report 2006–2008. New York, NY: Department of Health, New York State. February 2016
    PubMedGoogle Scholar
  • 8 Burgansky A, Montalto D, Siddiqui NA. The safe motherhood initiative: the development and implementation of standardized obstetric care bundles in New York. Semin Perinatol 2016; 40 (02) 124-131
    CrossrefPubMedGoogle Scholar
  • 9 Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2015; 125 (02) 521-525
    CrossrefPubMedGoogle Scholar
  • 10 Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. ; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36 (05) 416-441
    CrossrefPubMedGoogle Scholar
  • 11 National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. London: RCOG Press; 2011
    Google Scholar
  • 12 Bernstein PS, Martin Jr JN, Barton JR. , et al. National partnership for maternal safety: consensus bundle on severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2017; 130 (02) 347-357
    CrossrefPubMedGoogle Scholar
  • 13 Main EK, Menard MK. Maternal mortality: time for national action. Obstet Gynecol 2013; 122 (04) 735-736
    CrossrefPubMedGoogle Scholar
  • 14 D'Alton ME, Bonanno CA, Berkowitz RL. , et al. Putting the “M” back in maternal-fetal medicine. Am J Obstet Gynecol 2013; 208 (06) 442-448
    CrossrefPubMedGoogle Scholar
  • 15 DʼAlton ME, Main EK, Menard MK, Levy BS. The national partnership for maternal safety. Obstet Gynecol 2014; 123 (05) 973-977
    CrossrefPubMedGoogle Scholar